Immune system dysregulation in adolescent major depressive disorder

被引:118
|
作者
Gabbay, Vilma [1 ]
Klein, Rachel G.
Alonso, Carmen M.
Babb, James S. [2 ]
Nishawala, Melissa
De Jesus, Georgette
Hirsch, Glenn S.
Hottinger-Blanc, Pauline M. Z.
Gonzalez, Charles J. [3 ]
机构
[1] NYU, Dept Child & Adolescent Psychiat, Sch Med, NYU Child Study Ctr, New York, NY 10016 USA
[2] NYU, Dept Radiol, Sch Med, New York, NY 10016 USA
[3] New York State Dept Hlth, AIDS Inst, Albany, NY 12237 USA
关键词
Major depressive disorder; Adolescent depression; Cytokines; Interferon-gamma; Interleukin-6; Th1/Th2; INTERFERON-GAMMA; CYTOKINE IMBALANCE; BIPOLAR DISORDER; ALPHA; TRYPTOPHAN; CHILDREN; PATHOPHYSIOLOGY; SCHIZOPHRENIA; INTERLEUKIN-6; AVAILABILITY;
D O I
10.1016/j.jad.2008.07.022
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A large body of evidence suggests that immune system dysregulation is associated with Major Depressive Disorder (MDD) in adults. This study extends this work to adolescent MDD to examine the hypotheses of immune system dysregulation in adolescents with MDD, as manifested by significantly: (i) elevated plasma levels of cytokines (interferon [IFN]-gamma, turner necrosis factor-alpha, interleukin [IL]-6, IL-1 beta, and IL-4); and (ii) Th1/Th2 cytokine imbalance shifted toward Th1 as indexed by increased IFN-gamma/IL-4. Method: Thirty adolescents with MDD (19 females; 13 medication-firee/naive;, ages 12-19) of at least 6 weeks duration and a minimum severity score of 40 on the Children's Depression Rating Scale-Revised, and 15 healthy comparisons (8 females), group-matched for age, were enrolled. Plasma cytokines were examined using enzyme-linked immunosorbent assay. Mann-Whitney test was used to compare subjects with MDD and controls. Results: Adolescents with MDD had significantly elevated plasma IFN-gamma levels (3.38 +/- 11.8 pg/ml versus 0.37 +/- 0.64 pg/ml; p<0.003), and IFN-gamma/IL-4 ratio (16.6 +/- 56.5 versus 1.76 +/- 2.28; p=0.007). A trend for IL-6 to be elevated in the MDD group was also observed (1.52 +/- 2.88 pg/ml versus 0.49 +/- 0.90 pg/ml; p=0.09). Importantly, findings remained evident when medicated subjects were excluded. Conclusions: Findings suggest that immune system dysregulation may be associated with adolescent MDD, with an imbalance of Th1/Th2 shifted toward Th1, as documented in adult MDD. Larger studies with medication-free adolescents should follow. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 50 条
  • [1] The role of anxious distress in immune dysregulation in patients with major depressive disorder
    Roxanne Gaspersz
    Femke Lamers
    Gayle Wittenberg
    Aartjan T. F. Beekman
    Albert M. van Hemert
    Robert A. Schoevers
    Brenda W. J. H. Penninx
    Translational Psychiatry, 7
  • [2] The role of anxious distress in immune dysregulation in patients with major depressive disorder
    Gaspersz, Roxanne
    Lamers, Femke
    Wittenberg, Gayle
    Beekman, Aartjan T. F.
    van Hemert, Albert M.
    Schoevers, Robert A.
    Penninx, Brenda W. J. H.
    TRANSLATIONAL PSYCHIATRY, 2017, 7
  • [3] Immune system dysregulation and major depressive disorder : IL-1 as a potential target of antidepressant agents
    Christopoulos, P.
    Hajantoni, K.
    Delastik, A. L.
    Panagoutsos, P.
    Papadopoulos, C.
    Gourzis, P.
    Mouzaki, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 72 - 73
  • [4] Anxious distress is associated with increased immune dysregulation in patients with major depressive disorder
    Gaspersz, R.
    Lamers, F.
    Wittenberg, G.
    Beekman, A.
    van Hemert, A.
    Schoevers, R.
    Penninx, B.
    EUROPEAN PSYCHIATRY, 2017, 41 : S158 - S158
  • [5] Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder
    Minelli, A.
    Magri, C.
    Barbon, A.
    Bonvicini, C.
    Segala, M.
    Congiu, C.
    Bignotti, S.
    Milanesi, E.
    Trabucchi, L.
    Cattane, N.
    Bortolomasi, M.
    Gennarelli, M.
    TRANSLATIONAL PSYCHIATRY, 2015, 5
  • [6] Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder
    A Minelli
    C Magri
    A Barbon
    C Bonvicini
    M Segala
    C Congiu
    S Bignotti
    E Milanesi
    L Trabucchi
    N Cattane
    M Bortolomasi
    M Gennarelli
    Translational Psychiatry, 2015, 5 (12) : e687 - e687
  • [7] Inflammatory Process and Immune System in Major Depressive Disorder
    Labra Ruiz, Norma Angelica
    Santamaria Del Angel, Daniel
    Osnaya Brizuela, Norma
    Valenzuela Peraza, Armando
    Juarez Olguin, Hugo
    Punzo Soto, Monica
    Calderon Guzman, David
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (01): : 46 - 53
  • [8] Dysregulation of the Lateral Habenula in Major Depressive Disorder
    Browne, Caroline A.
    Hammack, Robert
    Lucki, Irwin
    FRONTIERS IN SYNAPTIC NEUROSCIENCE, 2018, 10
  • [9] Dysregulation of brain dopamine systems in major depressive disorder
    Delva, Nella C.
    Stanwood, Gregg D.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (09) : 1084 - 1093
  • [10] Backtranslating Sex Differences in Peripheral Immune Dysregulation From Patients With Major Depressive Disorder to Mice
    Rainville, Jennifer
    Riskus, Sadie
    Xue, Xianging
    Huskey, Alisa
    Murrough, James
    Seney, Marianne
    Hodes, Georgia
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 273 - 273